Terms: = Brain cancer AND LDH AND Treatment
151 results:
1. Construction of brain metastasis prediction model in limited stage small cell lung cancer patients without prophylactic cranial irradiation.
Guo J; Liu J; Ye W; Xu J; Zhong W; Zhang X; Yuan H; Shi H; Li T; Xu Y; Mao J; Shen B; Wu D
Clin Respir J; 2024 Jan; 18(1):e13730. PubMed ID: 38286746
[TBL] [Abstract] [Full Text] [Related]
2. BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Van Not OJ; van den Eertwegh AJM; Haanen JB; van Rijn RS; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Boers-Sonderen MJ; de Groot JWWB; Hospers GAP; Kapiteijn E; Bloem M; Piersma D; Stevense-den Boer M; Verheijden RJ; van der Veldt AAM; Wouters MWJM; Blokx WAM; Suijkerbuijk KPM
Cancer; 2024 May; 130(9):1673-1683. PubMed ID: 38198485
[TBL] [Abstract] [Full Text] [Related]
3. A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan.
Wada S; Ogata D; Kashihara T; Okuma K; Eto H; Nakano E; Takahashi A; Namikawa K; Igaki H; Yamazaki N
Cancer Med; 2023 Dec; 12(24):21933-21943. PubMed ID: 38083908
[TBL] [Abstract] [Full Text] [Related]
4. Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Wagner NB; Lenders MM; Kühl K; Reinhardt L; Fuchß M; Ring N; Stäger R; Zellweger C; Ebel C; Kimeswenger S; Oellinger A; Amaral T; Forschner A; Leiter U; Klumpp B; Hoetzenecker W; Terheyden P; Mangana J; Loquai C; Cozzio A; Garbe C; Meier F; Eigentler TK; Flatz L
Eur J Cancer; 2024 Jan; 196():113425. PubMed ID: 38039778
[TBL] [Abstract] [Full Text] [Related]
5. Elevated serum lactate dehydrogenase to albumin ratio is a useful poor prognostic predictor of nivolumab in patients with non-small cell lung cancer.
Menekse S; Kut E; Almuradova E
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):86-94. PubMed ID: 37869953
[TBL] [Abstract] [Full Text] [Related]
6. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
7. The Ratio of Key Metabolic Transcripts Is a Predictive Biomarker of Breast cancer Metastasis to the Lung.
Mathur D; Liao C; Lin W; La Ferlita A; Alaimo S; Taylor S; Zhong Y; Iacobuzio-Donahue C; Ferro A; Xavier JB
Cancer Res; 2023 Oct; 83(20):3478-3491. PubMed ID: 37526524
[TBL] [Abstract] [Full Text] [Related]
8. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes in patients with
Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto PA; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
Tumori; 2023 Dec; 109(6):537-545. PubMed ID: 37417313
[TBL] [Abstract] [Full Text] [Related]
10. Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase.
Pelizzari G; Bertoli E; Buriolla S; Vitale MG; Basile D; Palmero L; Zara D; Iacono D; Andrea F; Pascoletti G; Bolzonello S; Garutti M; Fasola G; Puglisi F; Minisini AM
Melanoma Res; 2023 Oct; 33(5):398-405. PubMed ID: 37402350
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.
Ochenduszko S; García Sanchez J; Fita MJJ; González-Barrallo I; Herrero Colomina J; Mujika K; Beveridge RD; Martínez SR; Lafuente BS; Tomas AC; Jaime AB; Cerezuela Fuentes P; Fra PL; Peeters AG; Meana García JA; García MAA; Altozano JP; Cancela M; Puchades AM; Roca FF; Maiques IM
Pigment Cell Melanoma Res; 2023 Sep; 36(5):388-398. PubMed ID: 37243929
[TBL] [Abstract] [Full Text] [Related]
12. RNA Sequencing in Hypoxia-Adapted T98G Glioblastoma Cells Provides Supportive Evidence for IRE1 as a Potential Therapeutic Target.
White BE; Liu Y; Hakonarson H; Buono RJ
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107600
[TBL] [Abstract] [Full Text] [Related]
13. A nomogram to predict the cumulative risk for brain metastases in patients with limited-stage small cell lung cancer without prophylactic cranial irradiation.
Liu J; Wu D; Shen B; Chen M; Zhou X; Zhang P; Qiu G; Ji Y; Du X; Yang Y
Strahlenther Onkol; 2023 Aug; 199(8):727-738. PubMed ID: 37103529
[TBL] [Abstract] [Full Text] [Related]
14. NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR brain PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
Samsonia M; Kandelaki M; Baratashvili N; Gvaramia L
Georgian Med News; 2023 Feb; (335):111-118. PubMed ID: 37042600
[TBL] [Abstract] [Full Text] [Related]
15. Palliative Radiotherapy for Non-metastatic Non-small-cell Lung cancer: Impact of Blood Test Results on Survival.
Nieder C; Imingen KS
In Vivo; 2023; 37(2):771-776. PubMed ID: 36881095
[TBL] [Abstract] [Full Text] [Related]
16. Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.
Tran TA; Kim YH; Duong TH; Thangaraj J; Chu TH; Jung S; Kim IY; Moon KS; Kim YJ; Lee TK; Lee CW; Yun H; Lee JJ; Lee HJ; Lee KH; Jung TY
Front Immunol; 2022; 13():1009484. PubMed ID: 36703992
[TBL] [Abstract] [Full Text] [Related]
17. Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Hasanov M; Milton DR; Davies AB; Sirmans E; Saberian C; Posada EL; Opusunju S; Gershenwald JE; Torres-Cabala CA; Burton EM; Colen RR; Huse JT; Glitza Oliva IC; Chung C; McAleer MF; McGovern SL; Yeboa DN; Kim BYS; Prabhu SS; McCutcheon IE; Weinberg JS; Lang FF; Tawbi HA; Li J; Haydu LE; Davies MA; Ferguson SD
Neuro Oncol; 2023 Jul; 25(7):1310-1320. PubMed ID: 36510640
[TBL] [Abstract] [Full Text] [Related]
18. Central nervous system involvement by mantle cell lymphoma.
McLaughlin N; Wang Y; Witzig T; Villasboas J; Habermann T; Inwards D; Bennani N; Thanarajasingam G; Nowakowski G; Porrata L; Thompson C; Micallef I; Johnston P; Ansell S; Paludo J
Leuk Lymphoma; 2023 Feb; 64(2):371-377. PubMed ID: 36416595
[TBL] [Abstract] [Full Text] [Related]
19. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract] [Full Text] [Related]
20. An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases.
Dutriaux C; Robert C; Grob JJ; Mortier L; Dereure O; Lebbe C; Mansard S; Grange F; Neidhardt EM; Lesimple T; Machet L; Bedane C; Maillard H; Dalac-Rat S; Nardin C; Szenik A; Denden A; Saiag P
Eur J Cancer; 2022 Nov; 175():254-262. PubMed ID: 36170791
[TBL] [Abstract] [Full Text] [Related]
[Next]
